MCRB: Seres Therapeutics, Inc. Stock

by  •  • Comments Off on MCRB: Seres Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 64.51
Enterprise Value ($M) 38.93
Book Value ($M) 13.78
Book Value / Share 0.08
Price / Book 5.06
NCAV ($M) -87.35
NCAV / Share -0.50
Price / NCAV -0.80

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.94
Current Ratio 0.94

Balance Sheet (mrq) ($M)
Current Assets 38.67
Assets 139.81
Liabilities 126.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -121.31
Net Income 0.14
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -148.61
Cash from Investing 142.29
Cash from Financing -90.37

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 12.80 12.50
10-02 13D/A Nestle Sa 14.29
2024-04-05 13G/A BlackRock, Inc. 4.50 -7.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,076,350 2,542,311 42.34
2025-04-16 1,588,795 4,401,492 36.10
2025-04-15 991,687 2,742,932 36.15
2025-04-14 199,401 1,013,203 19.68

(click for more detail)

Similar Companies
LVTX – LAVA Therapeutics N.V. LXRX – Lexicon Pharmaceuticals, Inc.
LYEL – Lyell Immunopharma, Inc. MDGL – Madrigal Pharmaceuticals, Inc.
MGNX – MacroGenics, Inc.


Financial data and stock pages provided by
Fintel.io